×
About 3,679 results

ALLMedicine™ Bone Tumors Center

Research & Reviews  1,813 results

The Italian consensus conference on the role of rehabilitation for children and adolesc...
https://doi.org/10.1002/pbc.28681
Pediatric Blood & Cancer REFERENCES; Rossi F, Ricci F et. al.

Sep 17th, 2020 - Because of increasing survival rates in pediatric oncology, attention is focusing on cancer and its treatment-related side effects. Rehabilitation may reduce their impact. However, the literature does not provide strong evidence regarding rehabili...

Extended analysis of intratumoral heterogeneity of primary osteosarcoma tissue using 3D...
https://doi.org/10.3233/CH-209204
Clinical Hemorheology and Microcirculation; Feder AL, Pion E et. al.

Sep 14th, 2020 - Osteosarcomas are a rare, heterogeneous and malignant group of bone tumors that have a high potential for metastasis and aggressive growth patterns. Treatment of metastasized osteosarcoma is often insufficient and research is compromised by proble...

Rare Osteochondroma of the Posterior Talar Process: A Case Report.
https://doi.org/10.7547/20-012
Journal of the American Podiatric Medical Association; Pham L, Wu D

Sep 11th, 2020 - Osteochondromas are benign bone tumors that arise from divergent cartilage formation most commonly in childhood versus adulthood. We report the case of a 42-year-old healthy female who presented with a unusual solitary posterolateral ankle mass wi...

Imaging Pediatric Bone Tumors.
https://www.ncbi.nlm.nih.gov/pubmed/32879016
Radiologic Technology; Wood J

Sep 3rd, 2020 - Primary bone tumors are the sixth most common type of tumor diagnosed in children. When evaluating bone lesions, specific characteristics-tumor margin, pattern of bone destruction, periosteal reaction, presence or absence of soft tissue mass, lesi...

Denosumab for Effective Tumor Size Reduction in Patients With Giant Cell Tumors of the ...
https://doi.org/10.1177/1073274820934822
Cancer Control : Journal of the Moffitt Cancer Center; Yayan J

Aug 31st, 2020 - Denosumab is a human monoclonal antibody that has been used successfully in the treatment of giant cell tumors of bone. These tumors are rare and, in principle, benign, but they are highly aggressive, locally advanced, osteolytic bone tumors that ...

see more →

Guidelines  3 results

ACR Appropriateness Criteria® Primary Bone Tumors.
https://doi.org/10.1016/j.jacr.2020.01.038
Journal of the American College of Radiology : JACR; , Bestic JM et. al.

May 5th, 2020 - Although primary bone tumors are relatively uncommon, appropriate imaging evaluation is essential when they are suspected or incidentally detected. In almost all cases, radiographs are the most appropriate initial imaging study for screening and c...

Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment an...
https://academic.oup.com/annonc/article/29/Supplement_4/iv79/5115250
Casali, P

Sep 30th, 2018 - Primary bone tumours are rare, accounting for < 0. 2% of malignant neoplasms registered in the EUROCARE (European Cancer Registry based study on survival and care of cancer patients) database [1].

NCCN Guidelines Insights: Bone Cancer, Version 2.2017
http://www.jnccn.org/content/15/2/155.full
Biermann, J.,et al

Jan 31st, 2017 - The NCCN Guidelines for Bone Cancer provide interdisciplinary recommendations for treating chordoma, chondrosarcoma, giant cell tumor of bone, Ewing sarcoma, and osteosarcoma. These NCCN Guidelines Insights summarize the NCCN Bone Cancer Panel's g.

see more →

Clinicaltrials.gov  1,841 results

The Italian consensus conference on the role of rehabilitation for children and adolesc...
https://doi.org/10.1002/pbc.28681
Pediatric Blood & Cancer REFERENCES; Rossi F, Ricci F et. al.

Sep 17th, 2020 - Because of increasing survival rates in pediatric oncology, attention is focusing on cancer and its treatment-related side effects. Rehabilitation may reduce their impact. However, the literature does not provide strong evidence regarding rehabili...

Extended analysis of intratumoral heterogeneity of primary osteosarcoma tissue using 3D...
https://doi.org/10.3233/CH-209204
Clinical Hemorheology and Microcirculation; Feder AL, Pion E et. al.

Sep 14th, 2020 - Osteosarcomas are a rare, heterogeneous and malignant group of bone tumors that have a high potential for metastasis and aggressive growth patterns. Treatment of metastasized osteosarcoma is often insufficient and research is compromised by proble...

Rare Osteochondroma of the Posterior Talar Process: A Case Report.
https://doi.org/10.7547/20-012
Journal of the American Podiatric Medical Association; Pham L, Wu D

Sep 11th, 2020 - Osteochondromas are benign bone tumors that arise from divergent cartilage formation most commonly in childhood versus adulthood. We report the case of a 42-year-old healthy female who presented with a unusual solitary posterolateral ankle mass wi...

Imaging Pediatric Bone Tumors.
https://www.ncbi.nlm.nih.gov/pubmed/32879016
Radiologic Technology; Wood J

Sep 3rd, 2020 - Primary bone tumors are the sixth most common type of tumor diagnosed in children. When evaluating bone lesions, specific characteristics-tumor margin, pattern of bone destruction, periosteal reaction, presence or absence of soft tissue mass, lesi...

Denosumab for Effective Tumor Size Reduction in Patients With Giant Cell Tumors of the ...
https://doi.org/10.1177/1073274820934822
Cancer Control : Journal of the Moffitt Cancer Center; Yayan J

Aug 31st, 2020 - Denosumab is a human monoclonal antibody that has been used successfully in the treatment of giant cell tumors of bone. These tumors are rare and, in principle, benign, but they are highly aggressive, locally advanced, osteolytic bone tumors that ...

see more →

News  9 results

Multifocal Langerhans Cell Histiocytosis in an Adult
https://www.mdedge.com/surgery/article/104887/knee/multifocal-langerhans-cell-histiocytosis-adult/page/0/3?channel=264

Dec 3rd, 2015 - Eosinophilic granuloma represents less than 1% of all bone tumors, and adult presentation is very rare. The differential diagnosis of lytic bone lesions is broad and includes metastatic carcinoma, lymphoma/myeloma, osteomyelitis, osteoblastoma, an.

High-Risk Musculoskeletal Injuries
https://www.mdedge.com/emergencymedicine/article/87370/imaging/high-risk-musculoskeletal-injuries/page/0/1

Sep 1st, 2014 - Tumors Back or bone pain can be a subtle early presenting symptom of cancer or tumors of the bone or bone marrow. The most common malignant bone tumors in children are osteosarcoma and Ewing sarcoma.

Commentary to "Patient-Specific Imaging and Missed Tumors: A Catastrophic Outcome"
https://www.mdedge.com/surgery/article/79129/imaging/commentary-patient-specific-imaging-and-missed-tumors-catastrophic?channel=264
Peh WCG

Dec 2nd, 2013 - The idiom “penny wise, pound foolish” certainly applies in this report of 2 cases of missed bone tumors that were present but not recognized on preoperative imaging prior to placement of patient-specific knee arthroplasties. The case report appear.

Girl, 13, With a Bump on Her Leg
https://www.mdedge.com/clinicianreviews/article/76179/orthopedics/girl-13-bump-her-leg/page/0/1

Jul 11th, 2013 - DISCUSSION Osteochondromas, which may be present in up to 3% of the general population, are the most common benign bone tumors. 1-3 An osteochondroma is a cartilage-capped bony projection that arises on the external surface of the bone; it contains.

FDA approves radiotherapy for metastatic prostate cancer
https://www.mdedge.com/surgery/article/58799/mens-health/fda-approves-radiotherapy-metastatic-prostate-cancer
Elizabeth Mechcatie

May 15th, 2013 - Radium-223 dichloride, an alpha-particle–emitting radioactive agent, has been approved for treating men with castration-resistant prostate cancer that has spread to the bones, the Food and Drug Administration announced on May 15. The agent "binds.

see more →

Patient Education  13 results see all →